Using health technology assessment to support optimal use of technologies in current practice: The challenge of "disinvestment"

International Journal of Technology Assessment in Health Care

Volumn 28, Issue 3, 2012, Pages 203-210

  Henshall, Chris ^a   Schuller, Tara ^b   Mardhani Bayne, Logan ^b  

^a UNIVERSITY OF YORK   (United Kingdom)

^b Health Technology Assessment International Secretariat   (United Kingdom)

Author keywords

Biomedical; Coverage; Disinvestment; Reimbursement; Technology assessment

Indexed keywords

BIOMEDICAL; COVERAGE; DISINVESTMENT; REIMBURSEMENT; TECHNOLOGY ASSESSMENTS;

DECISION MAKING; HEALTH; INVESTMENTS; TECHNOLOGY;

OPTIMIZATION;

ARTICLE; DECISION MAKING; DISINVESTMENT; HEALTH CARE ACCESS; HEALTH CARE FINANCING; HEALTH CARE ORGANIZATION; HEALTH CARE POLICY; HEALTH CARE SYSTEM; HEALTH TECHNOLOGY ASSESSMENT; INVESTMENT; QUALITY CONTROL; SAFETY; TECHNOLOGY;

BIOMEDICAL TECHNOLOGY; CONGRESSES AS TOPIC; EFFICIENCY, ORGANIZATIONAL; HEALTH FACILITIES; POLICY MAKING; TECHNOLOGY ASSESSMENT, BIOMEDICAL;

EID: 84866378701     PISSN: 02664623     EISSN: 14716348     Source Type: Journal    
DOI: 10.1017/S0266462312000372     Document Type: Article

References (24)

1. Busse R, Orvain J, Velasco M, et al. Best practice in undertaking and reporting health technology assessments. Working group 4 report. Int J Technol Assess Health Care. 2002;18:361-422. (Pubitemid 34533752)
2. Centre for Health Economics Research and Education. Reducing the use of ineffective health care interventions. CHERE Report for NSW Treasury. 2010. Working Paper 2010/5. http://www.chere.uts.edu.au/pdf/wp2010-5.pdf (accessed January 15, 2012).
3. Elshaug A, Hiller J, Tunis SR, Moss Jr. Challenges in Australian policy processes for disinvestment from existing, ineffective health care practices. Aust New Zealand Health Policy. 2007;4:23.
4. Elshaug A, Hiller JE, Moss Jr. Exploring policy makers' perspectives on disinvestment from ineffective healthcare practices. Int J Technol Assess Health Care. 2008;24:1-9. (Pubitemid 351158537)
5. Elshaug A, Moss JR, Littlejohns P, et al. Identifying existing health care services that do not provide value for money. Med J Aust. 2009;190:269-273.
6. Galician Agency for HTA. Avalia-T. PriTec tool for obsolete heath technologies. http://pritectools.es/Controlador/documentosAction.php (accessed January 28, 2012).
7. Garner S, Littlejohns P. Disinvestment from low value clinical interventions: NICEly done? BMJ. 2011;343:d4519.
8. Gerdvilaite J, Nachtnebel A. Disinvestment. Overview of disinvestment experiences and challenges in selected countries. HTA-Projektbericht 57, Ludwig Boltzmann Institut; 2011.
9. Health Technology Assessment International (HTAi). http://www.htai.org (accessed February 2012).
10. Health Technology Assessment International (HTAi). Policy forum. http://www.htai.org/index.php?id=643 (accessed February 2012).
11. Henshall C. The HTAi Policy Forum: Promoting public-private sector dialogue on the development and use of HTA in health system decision making. Michael Q. 2012;9:157-164.
12. HTAi Secretariat and Policy Forum Committee. HTAi Policy Forum Meeting 2012: HTA and Disinvestment: Harnessing HTA to reduce lower value or ineffective uses of health technologies. Background Paper. January 2012. http://www.htai.org/fileadmin/HTAi-Files/Policy-Forum-Public/ HTAi-Policy-Forum-2012-Background-Paper.pdf (accessed February 2012).
13. Ibargoyen-Roteta N, Gutierrez-Ibarluzea I, Asua J, et al. Scanning the horizon of obsolete technologies: Possible sources for their identification. Int J Technol Assess Health Care. 2009;25:249-254.
14. Ibargoyen-Roteta N, Gutiérrez-Ibarluzea I, Asua J. 2009. Report on the development of the GuNFT Guideline. Guideline for Not Funding existing health Technologies in health care systems. Quality Plan for the NHS of thlan for the NHS of the MHSP. Basque Office for Health Technology Assessment (Osteba). Health Technology Assessment Reports: OSTEBA N̊ 2007/11. http://www9.euskadi.net/sanidad/osteba/datos/e-10-11-report-GuNFT.pdf (accessed November 18, 2011).
15. Kahneman D, Tversky A. Prospect theory: An analysis of decision under risk. In: Kahneman D, Tversky A, eds. Choices, values, and frames. Cambridge, UK: Cambridge University Press; 2000:17-43. (reprinted from Econometrica 47; 2. 1979;263-291).
16. Kahneman D. Prospect theory. In: Thinking, fast and slow. New York: Farrar, Krause, and Giroux; 2011:278-288.
17. Klemp M, Frønsdal KB, Facey K. What principles should govern the use of managed entry agreements? Int J Technol Assess Health Care. 2011;27:77-83.
18. Kristenden FB, Sigmund H, eds. Health Technology Assessment Handbook. 2nd ed. Copenhagen: Danish Centre for Evaluation and Health Technology Assessment, National Board of Health; 2007. http://www.sst.dk/publ/Publ2008/MTV/Metode/HTA- Handbook
19. McCabe CJ, Stafinski T, Edlin R, Menon D. Banff AED Summit. Access with evidence development schemes: A framework for description and evaluation. Pharmacoeconomics. 2010;28:143-152.
20. Mitton C, Dionne F, Damji R, et al. Difficult decisions in times of constraint: Criteria based Resource Allocation in the Vancouver Coastal Health Authority. BMC Health Serv Res. 2011;11:169.
21. Mørland B. Using HTAs to support disinvestment-the case of sleep apnoea (OSAS) in Norway. Power Point presentation from the 27th Conference of the International Society for Quality in Health Care. 2010.
22. Porter ME. What is value in health care? N Engl J Med. 2010;363:2477-2481.
23. Ruano Raviña A, Velasco González M, Varela Lema L, et al. 2007. Identification, prioritisation and assessment of obsolete health technologies. A methodological guideline Quality Plan for the National Health System. Galician Agency for Health Technology Assessment, Avalia-T. http://www.sergas.es/docs/Avalia-t/ObsoleteTechMemFinal.pdf (accessed November 18, 2011).
24. Wulff KC, Miller FG, Pearson SD. Can coverage be rescinded when negative trial results threaten a popular procedure? The ongoing saga of vertebroplasty. Health Aff (Millwood). 2011;30:2269-2276.